炎症
促炎细胞因子
调解人
甲基化
生物
白细胞介素23
染色质
免疫学
细胞因子
长非编码RNA
核糖核酸
DNA甲基化
发病机制
癌症研究
基因表达
细胞生物学
基因
遗传学
白细胞介素17
作者
Ane Olazagoitia‐Garmendia,Henar Rojas‐Márquez,Maialen Sebastian‐delaCruz,Aloña Agirre‐Lizaso,Anne Ochoa,Luis Manuel Mendoza‐Gomez,María J. Perugorria,Luís Bujanda,Alaín Huerta,Izortze Santín,Ainara Castellanos‐Rubio
标识
DOI:10.1002/advs.202307928
摘要
Abstract Cytokine mediated sustained inflammation increases the risk to develop different complex chronic inflammatory diseases, but the implicated mechanisms remain unclear. Increasing evidence shows that long noncoding RNAs (lncRNAs) play key roles in the pathogenesis of inflammatory disorders, while inflammation associated variants are described to affect their function or essential RNA modifications as N 6 ‐methyladenosine (m 6 A) methylation, increasing predisposition to inflammatory diseases. Here, the functional implication of the intestinal inflammation associated lncRNA LOC339803 in the production of cytokines by intestinal epithelial cells is described. Allele‐specific m 6 A methylation is found to affect YTHDC1 mediated protein binding affinity. LOC339803 ‐YTHDC1 interaction dictates chromatin localization of LOC339803 ultimately inducing the expression of NFκB mediated proinflammatory cytokines and contributing to the development of intestinal inflammation. These findings are confirmed using human intestinal biopsy samples from different intestinal inflammatory conditions and controls. Additionally, it is demonstrated that LOC339803 targeting can be a useful strategy for the amelioration of intestinal inflammation in vitro and ex vivo. Overall, the results support the importance of the methylated LOC339803 lncRNA as a mediator of intestinal inflammation, explaining genetic susceptibility and presenting this lncRNA as a potential novel therapeutic target for the treatment of inflammatory intestinal disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI